Evicenter
P&T meetings

Cytisinicline

Smoking cessation

Last updated
86 sources

Clinical evidence

NCT04286295

9 evidence topics · 1 source

Objective
Location and study date

No evidence found.

Study design
Eligibility criteria
Treatment
Treatment course
CharacteristicQuoted value
Cytisine or combination nicotine replacement therapy“25 days”
Study outcomes
Rationale for using recruitment and treatment adherence as the primary feasibility endpoints
Statistical analysis description
Number of participants (Planned and analyzed)
Recruitment
CharacteristicQuoted value
Recruited participants“13”
Description of analysis sets

No evidence found.

Results
Participant disposition
Baseline characteristics

No evidence found.

Efficacy results
Participants abstinent at day 25
CharacteristicQuoted value
Cytisine“1”
Nicotine replacement therapy“0”
Health-related quality of life and patient-reported outcomes

No evidence found.

Safety results

No evidence found.

Study limitations
Summary

This pilot recruited 13 participants and nine completed follow-up. It was designed to evaluate recruitment and adherence, not to provide a definitive comparative efficacy estimate. Its end-of-treatment cessation findings are therefore exploratory.